For the Quarter Ending September 2025
North America
• In United States, the Dexamethasone Sodium Phosphate Price Index rose in Q3 2025, driven by rising costs and robust healthcare demand.
• Production costs increased, with CPI up 3.0% (September 2025) and PPI up 2.6% (August 2025).
• Demand outlook remained strong, supported by 5.42% retail sales growth and 4.3% unemployment in September 2025.
• Raw materials inventory levels contracted in Q3 2025, indicating tightening Dexamethasone Sodium Phosphate supply.
• Industrial electricity prices increased in August 2025, raising Dexamethasone Sodium Phosphate manufacturing expenses.
• US natural gas prices showed an uptick during Q3 2025, impacting Dexamethasone Sodium Phosphate production costs.
• US healthcare spending is projected to increase in 2025, bolstering Dexamethasone Sodium Phosphate demand.
• The Dexamethasone Sodium Phosphate Price Index is forecast to remain firm due to persistent cost pressures.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in North America?
• Rising input costs, evidenced by 3.0% CPI increase in September 2025, elevated production expenses.
• Strong consumer spending, with retail sales up 5.42% in September 2025, supported pharmaceutical demand.
• Contracted raw materials inventory levels in Q3 2025 contributed to tighter Dexamethasone Sodium Phosphate supply.
APAC
• In China, the Dexamethasone Sodium Phosphate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
• Production costs decreased as the Producer Price Index fell by 2.3% in September 2025, impacting raw material expenses.
• Demand for Dexamethasone Sodium Phosphate strengthened in Q3 2025, driven by an aging population and chronic disease prevalence.
• The Manufacturing Index was contracting in September 2025, indicating a slowdown in industrial activity and potential supply chain disruptions.
• Industrial production grew by 6.5% year-on-year in September 2025, supporting a stable supply of necessary raw materials.
• Overall chemical overcapacity intensified in 2025, with high inventories contributing to downward price pressure in Q3 2025.
• Consumer confidence remained pessimistic at 89.6 in September 2025, with CPI falling 0.3%, dampening overall healthcare spending.
• Pharmaceutical exports from Shanghai surged in Q1-Q3 2025, partially offsetting soft domestic Dexamethasone Sodium Phosphate demand.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in APAC?
• Producer prices declined by 2.3% in September 2025, directly reducing Dexamethasone Sodium Phosphate manufacturing costs.
• Global chemical overcapacity intensified in 2025, leading to high inventories and downward price pressure.
• Soft domestic consumer demand, with 3.0% retail sales growth, and contracting manufacturing activity contributed to price declines.
Europe
• In Germany, Dexamethasone Sodium Phosphate Price Index rose in Q3 2025, driven by surging API prices.
• Production costs faced upward pressure from a 2.4% CPI increase in September 2025, reflecting inflation.
• A 1.7% PPI decline in September 2025, due to lower energy prices, partially mitigated production costs.
• The Manufacturing Index contracted in Q3 2025, signaling industrial slowdown and demand constraints.
• Dexamethasone Sodium Phosphate demand was impacted by a 1.0% industrial production decline in September 2025.
• Natural gas prices in Germany moderated in Q3 2025, showing a downward trend, easing energy costs.
• API prices surged in July 2025 due to logistical issues, increasing raw material expenses.
• Germany's chemical and pharmaceutical industry production declined in Q3 2025, alongside reduced international sales.
• Modest 0.2% retail sales growth and stabilizing consumer confidence in Q3 2025 offered demand support.
• A 6.3% unemployment rate in September 2025 indicated economic weakness, limiting healthcare spending.
Why did the price of Dexamethasone Sodium Phosphate change in September 2025 in Europe?
• API prices surged in September 2025 due to logistical issues, increasing Dexamethasone Sodium Phosphate input costs.
• A 2.4% CPI increase in September 2025 raised overall manufacturing and distribution expenses.
• Moderating natural gas prices in Q3 2025 partially offset cost pressures, but overall costs rose.
For the Quarter Ending December 2022
North America
In the North American region, the price of Dexamethasone Sodium Phosphate fluctuated throughout the fourth quarter of 2022. According to the data, the prices of Dexamethasone Sodium Phosphate first inclined in October and then further in November as a result of limited inventories of products among domestic retailers coupled with high demand from downstream pharmaceutical and healthcare industries.
Moving towards December, the prices started to follow a downward trajectory as market sources revealed that because of low offtakes for the product from regional buyers, traders got an opportunity to lower their prices. As a result, the prices of Dexamethasone Sodium Phosphate decreased with the settlement at USD 894650/MT in the United States by the end of the third quarter.
Asia- Pacific
Across the Asia-Pacific region, Dexamethasone Sodium Phosphate prices followed an upward trajectory in the first two months and began to decrease in early December 2022. In China, prices for Dexamethasone Sodium Phosphate demonstrated a rise of a total of 3.6% from 1st October to 30th November. As more COVID-19 instances caused disruptions, China's industrial activity, a key engine of the country's economic growth, began to deteriorate. Though, this caused a lack of supply amongst local manufacturers. After that, prices for Dexamethasone Sodium Phosphate began to decline in early December, being held back by a rise in domestic inventory levels accompanied by a decline in international demand. The end-user pharmaceutical market had a general trading environment, and the overall manufacturing of the product was primarily based on demand. Moreover, the worsened Covid-19 outbreak weakened transport activities, and the weak market dynamics pressed down the prices. With this, the price of Dexamethasone Sodium Phosphate settled at USD 875650/MT FOB Shanghai in China.
Europe
Major European countries like Germany started facing similar market fundamentals to that of the Asia-Pacific region, where Dexamethasone Sodium Phosphate prices were risen by a considerable fraction during the fourth quarter of 2022. The data shows a rise of around 5.5% for Germany by the first half of November 2022, supported by high offtakes from the downstream pharmaceutical and healthcare industries. However, inadequate inventories among German traders due to limited imports from China amid Covid-19 protocols propelled buyers to search for every possible stock in the market. Later, Dexamethasone Sodium Phosphate changed its pricing dynamics during December as supply chain disruption subsided in response to a decline in orders. However, end-user players mainly hold uncertain buying interests amid weak demand, resulting in a bearish market outlook. Thus, by the quarter ending December, prices were assessed at USD 918740/MT in Germany.
For the Quarter Ending September 2022
North America
During the first half of Q3, the price trend of Dexamethasone Sodium Phosphate inclined significantly by 2.7%, with a buoyant market sentiment in the North American region. The price surged to USD 911550/MT was supported by higher downstream demand and inquiries from the domestic market. Moving towards the second half of Q3, the prices started to follow a downward trajectory backed by an accumulation of inventories with local vendors. Eliminating the lockdown and resumption of production activities in the exporting countries kept the trading momentum firm in the US market. Overall, by the end of the third quarter, prices decreased with the settlement of USD 896730/MT CFR Los Houston in the United States.
Asia- Pacific
In the APAC region, the prices of Dexamethasone Sodium Phosphate witnessed mixed sentiments during the third quarter of 2022. During the H1 of Q3, the prices rose considerably at a stable rate owing to consistent demand from end-user pharmaceutical sectors and weakened inventories with the domestic market participants. Furthermore, the halt in production activities and port congestion led to accumulated shipments which supported the pricing tendency in the market. However, the prices declined by 3.8% following the H2 of Q3 as factories resumed production, resulting in enough inventories among manufacturers to meet the overall demand. With this, the price of Dexamethasone Sodium Phosphate settled at USD 870655/MT FOB Shanghai in China.
Europe
During the third quarter of 2022, Dexamethasone Sodium Phosphate showcased fluctuations in the price trend in the European region. A glimpse of beneficial market sentiments was flashed with a 4.6% leap in price in the H2 of Q3 on account of increased demand from the pharmaceutical and healthcare industries. By the second half of the quarter, feeble purchasing activities were observed due to lowering demand from the regional market, resulting in the price decline of Dexamethasone Sodium Phosphate. Domestic merchants were pessimist about the existing stock, due to which they lowered the prices in the German domestic market to increase their orders. As a ripple effect in Germany, the CFR Hamburg prices of Dexamethasone Sodium Phosphate settled at USD 904730/MT in September 2022.
For the Quarter Ending June 2022
North America
In the North American region, the Dexamethasone Sodium Phosphate API market showcased an upward trend due to favorable sentiments in the regional market during the second quarter of 2022. As Dexamethasone Sodium Phosphate API was imported from China, prices surged amidst the lockdown curb. In addition, supply constraints influenced by prolonged port congestion impacted the market in the United States. The value of Dexamethasone Sodium Phosphate was affected by high container freight expenses for import. The demand for Dexamethasone Sodium Phosphate API from the pharmaceutical sector increased. In the United States, the CFR price of Dexamethasone Sodium Phosphate inclined by 2.4% this quarter, with values assessed at USD 887130/MT.
Asia- Pacific
In Q2 2022, the Dexamethasone Sodium Phosphate API market witnessed positive market sentiments in Asia. The price of Dexamethasone Sodium Phosphate API followed an upward trajectory throughout the quarter. The enhancement in API price was due to strong demand and low inventories from the pharmaceutical sector. Due to limited supply, high production rates in major API manufacturing plants resulted in a spike in the cost of Dexamethasone Sodium Phosphate. In the Asia Pacific region, the price of Dexamethasone Sodium Phosphate in India settled at INR 55564750/MT Ex-Vapi with a quarterly inclination of 13.8%, whereas in China, the FOB price inclined by 3.3%, with values assessing at USD 892676/MT.
Europe
The Dexamethasone Sodium Phosphate API market climbed moderately in the European region during the second quarter of 2022 due to consistent offtakes from the downstream pharmaceutical sectors. In Europe, Germany showcased a soared behavior towards the Dexamethasone Sodium Phosphate API market due to increased raw material prices. The regional DSP cost has escalated due to rising energy and crude oil prices and the geopolitical conflict between Russia and Ukraine. In addition, rising production costs, rerouting of transportation, and a cargo scarcity that increased freight costs all affected API pricing in the market. This quarter saw a 3.1% increase in Dexamethasone Sodium Phosphate prices in Germany, with values assembling at USD 878320/MT in June.
